Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
New therapies like T-cell engagers and antibody-drug conjugates are showing survival gains in pretreated small cell lung ...
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Applicatio ...
The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer ...
In patients with type 2 diabetes (T2D), the use of GLP-1 receptor agonists was associated with a significantly lower risk for lung cancer than the use of DPP-4 inhibitors. GLP-1 receptor agonist use ...
Lung cancer causes abnormal cells to grow in your lungs. You are at higher risk for lung cancer if you are a current smoker or have smoked regularly in the past. But anyone can get lung cancer. In ...
New Lung Cancer treatment helping patients swap clinic hours for minutes.
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...
Doctors at Sarasota Memorial Hospital say a new early detection program is helping catch more lung cancers before symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results